More than 80% of DS cases are caused by de novo heterozygous mutations of SCN1A. The initial manifestations of DS start during the first year of life and consist of frequent, drug-resistant, and often prolonged seizures, typically triggered by hyperthermia. Here, SCN1A is linked to Dravet syndrome.